Apyx Medical Corporation (APYX) Stock Overview
Explore Apyx Medical Corporation’s financial performance, market position, analyst ratings, and future outlook.
Apyx Medical Corporation (APYX)
Key Financials
Key Financials
Market Cap
188.4M
P/E Ratio
-19.50
EPS (TTM)
$-0.22
ROE
-0.91%
APYX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Apyx Medical Corporation (APYX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 57.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.06.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.50 and a market capitalization of 188.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.